TP53 and outcome in DLBCL: not only the coding region.

4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Li et al report mutations in the 3' untranslated region (3'UTR) of TP53 that modify the expression of p53 and thus its effect on response to therapy in diffuse large B-cell lymphoma (DLBCL) patients.

Cite

CITATION STYLE

APA

Jardin, F., & Coiffier, B. (2013, May 30). TP53 and outcome in DLBCL: not only the coding region. Blood. https://doi.org/10.1182/blood-2013-04-493486

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free